U01GH002259
Cooperative Agreement
Overview
Grant Description
Advancing public health research in Bangladesh.
Grant Program (CFDA)
Awarding Agency
Place of Performance
Bangladesh
Geographic Scope
Foreign
Related Opportunity
Notes
COVID-19 $1,948,511 (10%) percent of this Cooperative Agreement was funded by COVID-19 emergency acts including the CARES Act and the American Rescue Plan Act of 2021.
Amendment Since initial award the total obligations have increased 2718% from $687,906 to $19,387,990.
Amendment Since initial award the total obligations have increased 2718% from $687,906 to $19,387,990.
Bangladesh International Centre For Diarrhoeal Disease Research was awarded
Cooperative Agreement U01GH002259
worth $19,387,990
from National Center for Immunization and Respiratory Diseases in September 2019.
The grant
has a duration of 5 years and
was awarded through assistance program 93.326 Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention.
Status
(Ongoing)
Last Modified 9/20/23
Period of Performance
9/30/19
Start Date
9/29/24
End Date
Funding Split
$19.4M
Federal Obligation
$0.0
Non-Federal Obligation
$19.4M
Total Obligated
Activity Timeline
Transaction History
Modifications to U01GH002259
Additional Detail
Award ID FAIN
U01GH002259
SAI Number
U01GH002259-453649234
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Non-Domestic (Non-U.S.) Entity
Awarding Office
75CDC1 CDC OFFICE OF FINANCIAL RESOURCES
Funding Office
75CVG0 CDC NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES
Performance District
Not Applicable
Modified: 9/20/23